短效神经肌肉阻滞改善心脏骤停后预后判断中正中神经体感诱发电位的评分者间信度
研究纳入30例昏迷的心脏骤停后存活者,在重症医师要求完成体感诱发电位(SSEP)进行预后判断时入组,每例患者在使用神经肌肉阻滞剂(NMB)前后分别记录左右正中神经SSEP。记录随机化后由5名盲法评分者评估皮质与非皮质电位的潜伏期和波幅(或反应缺失)及皮质记录的诊断质量,用Fleiss κ比较NMB前后评分者间信度。结果显示,NMB后皮质SSEP判读的Fleiss κ由0.37升至0.60,评分者报告皮质记录不可诊断的比例由40.7%降至17%,信噪比显著改善(尤其NMB前信噪比<10 dB时),并有3例患者判读由双侧缺失转为双侧存在(NMB前的潜在假阳性)。作者结论为NMB显著改善SSEP评分者间信度与信噪比,主张记录SSEP前应常规药物性肌松。
要点
- 30例昏迷心脏骤停后存活者中,使用NMB后皮质SSEP判读的Fleiss κ由0.37升至0.60,评分者间一致性提高。
- NMB后评分者报告皮质记录不可诊断的比例由40.7%降至17%。
- NMB后信噪比显著改善,尤其当NMB前信噪比<10 dB时。
- 5名盲法评分者中有3例患者的SSEP判读在NMB后由双侧缺失转为双侧存在,属NMB前的潜在假阳性。
- 作者结论:为确保昏迷心脏骤停后存活者获得最可靠的预后信息,记录SSEP前应常规使用药物性肌松。
适用人群与场景
- 昏迷的心脏骤停后存活者,因重症医师要求完成SSEP进行预后判断而入组,共30例。
处置流程与药物剂量
- 每例患者在使用NMB前后分别记录左右正中神经SSEP,记录随机化后由5名盲法评分者判读。
- 作者结论:记录SSEP前应常规使用药物性肌松,以确保最可靠的预后信息。
研究设计与关键结果
- 研究类型为纳入30例昏迷心脏骤停后存活者的研究,NMB前后各记录左右正中神经SSEP,由5名盲法评分者判读。
- NMB后皮质SSEP判读的Fleiss κ由0.37升至0.60,评分者间一致性提高。
- 评分者报告皮质记录不可诊断的比例:NMB前40.7%,NMB后17%。
- NMB后信噪比显著改善,尤其当NMB前信噪比<10 dB时。
- 5名评分者中有3例患者的SSEP判读在NMB后由双侧缺失转为双侧存在(NMB前的潜在假阳性)。
证据类型、等级与局限
- 证据类型:纳入30例昏迷心脏骤停后存活者的研究,临床病史与结局为回顾性复习。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,NMB显著改善昏迷心脏骤停后存活者正中神经SSEP预后判断的评分者间信度与信噪比。
- 作者建议,为确保最可靠的预后信息,昏迷心脏骤停后存活者记录SSEP前应常规使用药物性肌松。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although median nerve somatosensory evoked potentials are routinely used for prognostication in comatose cardiac arrest survivors, myogenic artifact can reduce inter-rater reliability, leading to unreliable or inaccurate results. To minimize this risk, we determined the benefit of neuromuscular blockade agents in improving the inter-rater reliability and signal-to-noise ratio of SSEPs in the context of prognostication.
METHODS: Thirty comatose survivors of cardiac arrest were enrolled in the study, following the request from an intensivist to complete an SSEP for prognostication. Right and left median nerve SSEPs were obtained from each patient, before and after administration of an NMB agent. Clinical histories and outcomes were retrospectively reviewed. The SSEP recordings before and after NMB were randomized and reviewed by five blinded raters, who assessed the latency and amplitude of cortical and noncortical potentials (vs. absence of response) as well as the diagnostic quality of cortical recordings. The inter-rater reliability of SSEP interpretation before and after NMB was compared via Fleiss' κ score.
RESULTS: Following NMB administration, Fleiss' κ score for cortical SSEP interpretation significantly improved from 0.37 to 0.60, corresponding to greater agreement among raters. The raters were also less likely to report the cortical recordings as nondiagnostic following NMB (40.7% nondiagnostic SSEPs pre-NMB; 17% post-NMB). The SNR significantly improved following NMB, especially when the pre-NMB SNR was low (< 10 dB). Across the raters, there were three patients whose SSEP interpretation changed from bilaterally absent to bilaterally present after NMB was administered (potential false positives without NMB).
CONCLUSIONS: NMB significantly improves the inter-rater reliability and SNR of median SSEPs for prognostication among comatose cardiac arrest survivors. To ensure the most reliable prognostic information in comatose post-cardiac arrest survivors, pharmacologic paralysis should be consistently used before recording SSEPs.
参考来源
- Oishi T, Triplett JD, Laughlin RS, et al. Short-Acting Neuromuscular Blockade Improves Inter-rater Reliability of Median Somatosensory Evoked Potentials in Post-cardiac arrest Prognostication. Neurocrit Care. 2022. PMID: 36123569. doi:10.1007/s12028-022-01601-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。